查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2028061

止血劑的市場規模、市場佔有率和成長率；全球產業分析；按類型、應用和地區進行分析；以及未來預測（2026-2034 年）。

Hemostats Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

止血劑市場成長要素

2025年全球止血劑市場價值為54.6億美元，預計2026年將成長至58.6億美元。到2034年，該市場預計將達到110.4億美元，2026年至2034年的複合年成長率為8.23%。

到2025年，北美將引領全球市場，佔34.96%的市場。這主要歸功於北美地區手術量龐大以及先進止血產品的快速普及。

介紹

止血劑是用來控制手術出血的重要醫療產品。它們透過最大限度地減少出血和降低併發症，在改善手術效果方面發揮著至關重要的作用。隨著心血管疾病、癌症和創傷等慢性疾病負擔的日益加重，全球對有效止血解決方案的需求也不斷成長。

市場趨勢

一個關鍵的市場趨勢是全球醫院和手術中心的數量不斷增加。醫療基礎設施的擴張促使手術數量增加，進而增加了對止血劑的需求。

此外，先進的可吸收止血產品的不斷推出提高了臨床療效，並正在加速其在醫療機構中的普及應用。

市場成長要素

1. 手術數量增加

全球範圍內，手術數量顯著增加。據估計，每年約有3.1億例大型手術。這一成長直接推高了對止血劑的需求，以有效控制出血併發症。

2. 慢性病盛行率增加

心血管疾病、癌症和其他慢性疾病的日益普遍，促使外科手術機會增加。這一趨勢是市場成長的主要驅動力。

3. 技術進步

止血產品的創新，例如纖維蛋白膠和多醣類藥物，提高了止血效率並降低了感染風險。這些進步拓寬了止血劑的應用範圍。

4. 創傷和事故案件增加

全球事故和創傷病例的增加進一步推高了外科手術的需求，進而增加了對止血產品的需求。

市場限制因素

儘管市場成長強勁，仍面臨諸多挑戰：

  • 先進止血產品高成本
  • 嚴重或無法控制的出血病例的臨床局限性
  • 對成本敏感型醫療保健系統的實施限制

這些因素可能會阻礙市場廣泛滲透。

市場區隔

副產品

  • 被動止血劑：由於其易於獲得且臨床接受度高，因此佔市場主導地位，預計到 2026 年將保持 48.21% 的市場佔有率。
  • 活性止血劑包括凝血酶類藥物和纖維蛋白膠。
  • 止血劑：由於產品創新不斷進步，預計該類別將具有最高的成長率。

用途別

  • 普通外科：由於手術量大，預計到 2026 年，這將成為一個主要細分市場，佔市場佔有率的 21.91%。
  • 其他應用領域包括心血管外科、創傷外科、整形外科、神經外科和整形外科。
  • 由於心臟相關疾病的增加，預計心血管外科手術將經歷最快的成長。

最終用戶

  • 醫院和門診手術中心（ASC）：由於大多數手術都是在這些機構中進行的，預計到 2026 年，它們將主導市場，佔總市場佔有率的 89.38%。
  • 其他部門包括戰術性傷亡救護 (TCCC) 中心和專科診所。

區域洞察

  • 北美：預計到 2025 年將成為最大的市場，規模達 19.1 億美元，預計到 2026 年將達到 20.4 億美元，這得益於先進的醫療基礎設施和大量的手術。
  • 歐洲：在強勁的醫療保健支出支持下，預計到 2025 年市場規模將達到 14.7 億美元，到 2026 年將成長至 15.5 億美元。
  • 亞太地區：受外科手術增加和醫療服務擴張的推動，預計該地區 2025 年將達到 13.4 億美元，2026 年將達到 14.7 億美元。
  • 拉丁美洲：預計到 2025 年市場規模將達到 4.5 億美元，到 2026 年將達到 4.9 億美元。
  • 中東和非洲：預計該地區到 2025 年將達到 2.9 億美元，到 2026 年將達到 3.1 億美元。

儘管面臨高成本和臨床應用限制等挑戰，但由於對有效止血解決方案的需求不斷成長以及醫療基礎設施的擴建，預計市場將繼續擴張。止血劑將繼續在全球醫療產業中發揮至關重要的作用，以提高手術安全性和患者療效。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 主要國家/地區重大外科手術數量（2025 年）
  • 主要疾病的流行病學：按主要國家分類
  • 關鍵產業趨勢：企業合併、商業合作
  • 新產品發布：按主要公司分類
  • 新冠疫情對市場的影響

第5章：全球止血劑市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：按產品分類
    • 活性止血劑
      • 基於凝血酶的止血劑
      • 纖維蛋白膠
    • 被動止血劑
      • 植物來源止血劑
      • 動物源性止血劑
      • 其他
    • 複方止血劑
    • 其他
  • 市場分析、洞察與預測：按應用領域分類。
    • 創傷
    • 心血管外科
    • 一般外科
    • 整形外科
    • 整形外科手術
    • 神經外科
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院/門診手術中心
    • 戰術性傷亡救護中心（TCCC）
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美止血劑市場分析：探討與預測（2021-2034 年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲止血劑市場分析：探討與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區止血劑市場分析：洞察與預測（2021-2034）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲和紐西蘭
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲止血劑市場分析：探討與預測（2021-2034 年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東與非洲止血劑市場分析：探討與預測（2021-2034 年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Baxter
    • Integra Life Sciences
    • Stryker
    • Artivion, Inc.
    • BD
    • Pfizer Inc.
    • Medtronic
    • Biom'up
    • Johnson & Johnson Services, Inc.
Product Code: FBI100084

Growth Factors of hemostats Market

The global hemostats market was valued at USD 5.46 billion in 2025 and is projected to grow to USD 5.86 billion in 2026. The market is expected to reach USD 11.04 billion by 2034, registering a CAGR of 8.23% during 2026-2034.

North America dominated the global market in 2025, accounting for a 34.96% share, driven by high surgical volumes and rapid adoption of advanced hemostatic products.

Introduction

Hemostats are critical medical products used to control bleeding during surgical procedures. They play an essential role in improving surgical outcomes by minimizing blood loss and reducing complications. With the growing burden of chronic diseases such as cardiovascular disorders, cancer, and trauma cases, the demand for effective bleeding control solutions is rising globally.

Market Trends

A major trend in the market is the increasing number of hospitals and surgical centers worldwide. The expansion of healthcare infrastructure is leading to a higher volume of surgeries, thereby increasing the demand for hemostatic agents.

Additionally, the continuous introduction of advanced and absorbable hemostatic products is improving clinical efficiency and driving adoption across healthcare facilities.

Market Growth Drivers

1. Rising Number of Surgical Procedures

Globally, the number of surgeries is increasing significantly. Estimates suggest that around 310 million major surgeries are performed annually. This rise directly increases the demand for hemostats to manage bleeding complications effectively.

2. Growing Prevalence of Chronic Diseases

The increasing incidence of cardiovascular diseases, cancer, and other chronic conditions is leading to more surgical interventions. This trend is a major factor contributing to market growth.

3. Technological Advancements

Innovations in hemostatic products, such as fibrin sealants and polysaccharide-based agents, are enhancing efficiency and reducing infection risks. These advancements are expanding the application scope of hemostats.

4. Increase in Trauma and Accident Cases

The rising number of accidents and trauma cases globally is further driving the need for surgical procedures and, consequently, hemostatic products.

Market Restraints

Despite strong growth, the market faces certain challenges:

  • High costs of advanced hemostatic products
  • Clinical limitations in cases of severe or uncontrolled bleeding
  • Restricted adoption in cost-sensitive healthcare systems

These factors may hinder widespread market penetration.

Market Segmentation

By Product

  • Passive Hemostats: Dominated the market and are expected to hold a 48.21% share in 2026, due to wide availability and strong clinical acceptance.
  • Active Hemostats: Include thrombin-based and fibrin sealants.
  • Combination Hemostats: Expected to grow at the fastest rate due to advanced product innovations.

By Application

  • General Surgery: Leading segment with a 21.91% share in 2026, driven by the high volume of procedures.
  • Other applications include cardiovascular surgery, trauma, orthopedic, neurosurgery, and plastic surgery.
  • Cardiovascular surgery is expected to witness the fastest growth due to increasing heart-related conditions.

By End-User

  • Hospitals & Ambulatory Surgical Centers (ASCs): Dominated with an 89.38% share in 2026, as most surgeries are conducted in these settings.
  • Other segments include tactical combat casualty care centers and specialty clinics.

Regional Insights

  • North America: Largest market with USD 1.91 billion in 2025, projected to reach USD 2.04 billion in 2026, driven by advanced healthcare infrastructure and high surgical volumes.
  • Europe: Valued at USD 1.47 billion in 2025, expected to grow to USD 1.55 billion in 2026, supported by strong healthcare spending.
  • Asia Pacific: Reached USD 1.34 billion in 2025, projected to reach USD 1.47 billion in 2026, driven by increasing surgeries and healthcare expansion.
  • Latin America: Valued at USD 0.45 billion in 2025, expected to reach USD 0.49 billion in 2026.
  • Middle East & Africa: Accounted for USD 0.29 billion in 2025, projected to reach USD 0.31 billion in 2026.

Competitive Landscape

The market is moderately consolidated, with major players such as Baxter, Ethicon (Johnson & Johnson), and BD (Becton, Dickinson and Company) leading due to strong product portfolios and continuous innovation.

Other key players include Integra LifeSciences, Stryker, Medtronic, Pfizer, and Biom'up. These companies focus on product launches, acquisitions, and regulatory approvals to strengthen their market presence.

Conclusion

The hemostats market is poised for robust growth, expanding from USD 5.46 billion in 2025 to USD 11.04 billion by 2034. The growth is primarily driven by the increasing number of surgical procedures, rising prevalence of chronic diseases, and continuous advancements in medical technologies.

Although high costs and clinical limitations pose challenges, the growing demand for effective bleeding management solutions and expanding healthcare infrastructure will sustain market expansion. Hemostats will continue to play a vital role in improving surgical safety and patient outcomes across the global healthcare industry.

Segmentation By Product

  • Active Hemostats
    • Thrombin Based Hemostats
    • Fibrin Sealants
  • Passive Hemostats
    • Plant-based Hemostats
    • Animal-based Hemostats
    • Others
  • Combination Hemostats
  • Others

By Application

  • Trauma
  • Cardiovascular Surgery
  • General Surgery
  • Plastic Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Others

By End-User

  • Hospitals & ASCs
  • Tactical Combat Casualty Care Centers
  • Others

By Region

  • North America (By Product, Application, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Application, End-User, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Application, End-User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Application, End-User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Application, End-User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Surgical Procedures, By Key Countries/Regions, 2025/2025
  • 4.2. Epidemiology of Key Diseases, By Key Countries/Regions
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. New Product Launches, By Key Players
  • 4.5. Impact of COVID-19 on the Market

5. Global Hemostats Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Active Hemostats
      • 5.1.1.1. Thrombin-based Hemostats
      • 5.1.1.2. Fibrin Sealants
    • 5.1.2. Passive Hemostats
      • 5.1.2.1. Plant-based Hemostats
      • 5.1.2.2. Animal-based Hemostats
      • 5.1.2.3. Others
    • 5.1.3. Combination Hemostats
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Trauma
    • 5.2.2. Cardiovascular Surgery
    • 5.2.3. General Surgery
    • 5.2.4. Plastic Surgery
    • 5.2.5. Orthopedic Surgery
    • 5.2.6. Neurosurgery
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Tactical Combat Casualty Care Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa

6. North America Hemostats Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Active Hemostats
      • 6.1.1.1. Thrombin-based Hemostats
      • 6.1.1.2. Fibrin Sealants
    • 6.1.2. Passive Hemostats
      • 6.1.2.1. Plant-based Hemostats
      • 6.1.2.2. Animal-based Hemostats
      • 6.1.2.3. Others
    • 6.1.3. Combination Hemostats
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Trauma
    • 6.2.2. Cardiovascular Surgery
    • 6.2.3. General Surgery
    • 6.2.4. Plastic Surgery
    • 6.2.5. Orthopedic Surgery
    • 6.2.6. Neurosurgery
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Tactical Combat Casualty Care Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast- By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Hemostats Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Active Hemostats
      • 7.1.1.1. Thrombin-based Hemostats
      • 7.1.1.2. Fibrin Sealants
    • 7.1.2. Passive Hemostats
      • 7.1.2.1. Plant-based Hemostats
      • 7.1.2.2. Animal-based Hemostats
      • 7.1.2.3. Others
    • 7.1.3. Combination Hemostats
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Trauma
    • 7.2.2. Cardiovascular Surgery
    • 7.2.3. General Surgery
    • 7.2.4. Plastic Surgery
    • 7.2.5. Orthopedic Surgery
    • 7.2.6. Neurosurgery
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Tactical Combat Casualty Care Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. UK
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Hemostats Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Active Hemostats
      • 8.1.1.1. Thrombin-based Hemostats
      • 8.1.1.2. Fibrin Sealants
    • 8.1.2. Passive Hemostats
      • 8.1.2.1. Plant-based Hemostats
      • 8.1.2.2. Animal-based Hemostats
      • 8.1.2.3. Others
    • 8.1.3. Combination Hemostats
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Trauma
    • 8.2.2. Cardiovascular Surgery
    • 8.2.3. General Surgery
    • 8.2.4. Plastic Surgery
    • 8.2.5. Orthopedic Surgery
    • 8.2.6. Neurosurgery
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Tactical Combat Casualty Care Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia & New Zealand
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Hemostats Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Active Hemostats
      • 9.1.1.1. Thrombin-based Hemostats
      • 9.1.1.2. Fibrin Sealants
    • 9.1.2. Passive Hemostats
      • 9.1.2.1. Plant-based Hemostats
      • 9.1.2.2. Animal-based Hemostats
      • 9.1.2.3. Others
    • 9.1.3. Combination Hemostats
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Trauma
    • 9.2.2. Cardiovascular Surgery
    • 9.2.3. General Surgery
    • 9.2.4. Plastic Surgery
    • 9.2.5. Orthopedic Surgery
    • 9.2.6. Neurosurgery
    • 9.2.7. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Tactical Combat Casualty Care Centers
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East and Africa Hemostats Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Active Hemostats
      • 10.1.1.1. Thrombin-based Hemostats
      • 10.1.1.2. Fibrin Sealants
    • 10.1.2. Passive Hemostats
      • 10.1.2.1. Plant-based Hemostats
      • 10.1.2.2. Animal-based Hemostats
      • 10.1.2.3. Others
    • 10.1.3. Combination Hemostats
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Trauma
    • 10.2.2. Cardiovascular Surgery
    • 10.2.3. General Surgery
    • 10.2.4. Plastic Surgery
    • 10.2.5. Orthopedic Surgery
    • 10.2.6. Neurosurgery
    • 10.2.7. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Tactical Combat Casualty Care Centers
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Baxter
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT analysis
      • 11.2.1.4. Recent developments
      • 11.2.1.5. strategies
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. Integra Life Sciences
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT analysis
      • 11.2.2.4. Recent developments
      • 11.2.2.5. strategies
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. Stryker
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT analysis
      • 11.2.3.4. Recent developments
      • 11.2.3.5. strategies
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. Artivion, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT analysis
      • 11.2.4.4. Recent developments
      • 11.2.4.5. strategies
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. BD
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT analysis
      • 11.2.5.4. Recent developments
      • 11.2.5.5. strategies
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. Pfizer Inc.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT analysis
      • 11.2.6.4. Recent developments
      • 11.2.6.5. strategies
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. Medtronic
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT analysis
      • 11.2.7.4. Recent developments
      • 11.2.7.5. strategies
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Biom'up
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT analysis
      • 11.2.8.4. Recent developments
      • 11.2.8.5. strategies
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Johnson & Johnson Services, Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT analysis
      • 11.2.9.4. Recent developments
      • 11.2.9.5. strategies
      • 11.2.9.6. financials (based on availability)

List of Tables

  • Table 1: Global Hemostats Market Revenue (USD Billion) Forecast, by Product, 2021-2034
  • Table 2: Global Hemostats Market Revenue (USD Billion) Forecast, by Active Hemostats, 2021-2034
  • Table 3: Global Hemostats Market Revenue (USD Billion) Forecast, by Passive Hemostats, 2021-2034
  • Table 4: Global Hemostats Market Revenue (USD Billion) Forecast, by Application, 2021-2034
  • Table 5: Global Hemostats Market Revenue (USD Billion) Forecast, by End User, 2021-2034
  • Table 6: Global Hemostats Market Revenue (USD Billion) Forecast, by Region, 2021-2034
  • Table 7: North America Hemostats Market Revenue (USD Billion) Forecast, by Product, 2021-2034
  • Table 8: North America Hemostats Market Revenue (USD Billion) Forecast, by Active Hemostats, 2021-2034
  • Table 9: North America Hemostats Market Revenue (USD Billion) Forecast, by Passive Hemostats, 2021-2034
  • Table 10: North America Hemostats Market Revenue (USD Billion) Forecast, by Application, 2021-2034
  • Table 11: North America Hemostats Market Revenue (USD Billion) Forecast, by End User, 2021-2034
  • Table 12: North America Hemostats Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Hemostats Market Revenue (USD Billion) Forecast, by Product, 2021-2034
  • Table 14: Europe Hemostats Market Revenue (USD Billion) Forecast, by Active Hemostats, 2021-2034
  • Table 15: Europe Hemostats Market Revenue (USD Billion) Forecast, by Passive Hemostats, 2021-2034
  • Table 16: Europe Hemostats Market Revenue (USD Billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Hemostats Market Revenue (USD Billion) Forecast, by End User, 2021-2034
  • Table 18: Europe Hemostats Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Hemostats Market Revenue (USD Billion) Forecast, by Product, 2021-2034
  • Table 20: Asia Pacific Hemostats Market Revenue (USD Billion) Forecast, by Active Hemostats, 2021-2034
  • Table 21: Asia Pacific Hemostats Market Revenue (USD Billion) Forecast, by Passive Hemostats, 2021-2034
  • Table 22: Asia Pacific Hemostats Market Revenue (USD Billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Hemostats Market Revenue (USD Billion) Forecast, by End User, 2021-2034
  • Table 24: Asia Pacific Hemostats Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Hemostats Market Revenue (USD Billion) Forecast, by Product, 2021-2034
  • Table 26: Latin America Hemostats Market Revenue (USD Billion) Forecast, by Active Hemostats, 2021-2034
  • Table 27: Latin America Hemostats Market Revenue (USD Billion) Forecast, by Passive Hemostats, 2021-2034
  • Table 28: Latin America Hemostats Market Revenue (USD Billion) Forecast, by Application, 2021-2034
  • Table 29: Latin America Hemostats Market Revenue (USD Billion) Forecast, by End User, 2021-2034
  • Table 30: Latin America Hemostats Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Hemostats Market Revenue (USD Billion) Forecast, by Product, 2021-2034
  • Table 32: Middle East & Africa Hemostats Market Revenue (USD Billion) Forecast, by Active Hemostats, 2021-2034
  • Table 33: Middle East & Africa Hemostats Market Revenue (USD Billion) Forecast, by Passive Hemostats, 2021-2034
  • Table 34: Middle East & Africa Hemostats Market Revenue (USD Billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Hemostats Market Revenue (USD Billion) Forecast, by End User, 2021-2034
  • Table 36: Middle East & Africa Hemostats Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Hemostats Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 2: Global Hemostats Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Hemostats Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Hemostats Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Hemostats Market Value (USD Billion), by Region, 2025 & 2034
  • Figure 6: North America Hemostats Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 7: North America Hemostats Market Value Share (%), by Product, 2025
  • Figure 8: North America Hemostats Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 9: North America Hemostats Market Value Share (%), by Application, 2025
  • Figure 10: North America Hemostats Market Value (USD Billion), by End User, 2025 & 2034
  • Figure 11: North America Hemostats Market Value Share (%), by End User, 2025
  • Figure 12: North America Hemostats Market Value (USD Billion), By Country, 2025 & 2034
  • Figure 13: North America Hemostats Market Value Share (%), By Country, 2025
  • Figure 14: Europe Hemostats Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 15: Europe Hemostats Market Value Share (%), by Product, 2025
  • Figure 16: Europe Hemostats Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 17: Europe Hemostats Market Value Share (%), by Application, 2025
  • Figure 18: Europe Hemostats Market Value (USD Billion), by End-user, 2025 & 2034
  • Figure 19: Europe Hemostats Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Hemostats Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Hemostats Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Hemostats Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Hemostats Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Hemostats Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Hemostats Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Hemostats Market Value (USD Billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Hemostats Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Hemostats Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Hemostats Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Hemostats Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 31: Latin America Hemostats Market Value Share (%), by Product, 202
  • Figure 32: Latin America Hemostats Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 33: Latin America Hemostats Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Hemostats Market Value (USD Billion), by End User, 2025 & 2034
  • Figure 35: Latin America Hemostats Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Hemostats Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Hemostats Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Hemostats Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Hemostats Market Value Share (%), by Product, 2025
  • Figure 40: Middle East & Africa Hemostats Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Hemostats Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Hemostats Market Value (USD Billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Hemostats Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Hemostats Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Hemostats Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Hemostats Market Share (%), By Company, 2025